Abeona therapeutics® reports third quarter 2024 financial results and recent corporate updates

Fda accepts bla resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets pdufa target action date of april 29, 2025
ABEO Ratings Summary
ABEO Quant Ranking